These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28776468)

  • 1. Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics.
    Just KS; Schneider KL; Schurig M; Stingl JC; Brockmöller J
    Pharmacogenomics; 2017 Aug; 18(13):1281-1297. PubMed ID: 28776468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
    Sikka R; Magauran B; Ulrich A; Shannon M
    Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of pharmacogenetics to pharmacovigilance.
    Bondon-Guitton E; Despas F; Becquemont L
    Therapie; 2016 Apr; 71(2):223-8. PubMed ID: 27080842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of adverse drug reactions in older patients].
    Burkhardt H; Wehling M; Gladisch R
    Z Gerontol Geriatr; 2007 Aug; 40(4):241-54. PubMed ID: 17701115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to adverse drug reactions in the intensive care unit.
    Empey PE
    Crit Care Med; 2010 Jun; 38(6 Suppl):S106-16. PubMed ID: 20502164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
    Pratt VM; Everts RE; Aggarwal P; Beyer BN; Broeckel U; Epstein-Baak R; Hujsak P; Kornreich R; Liao J; Lorier R; Scott SA; Smith CH; Toji LH; Turner A; Kalman LV
    J Mol Diagn; 2016 Jan; 18(1):109-23. PubMed ID: 26621101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic Testing for Analgesic Adverse Effects: Pediatric Case Series.
    Manworren RC; Jeffries L; Pantaleao A; Seip R; Zempsky WT; Ruaño G
    Clin J Pain; 2016 Feb; 32(2):109-15. PubMed ID: 25803758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical association between pharmacogenomics and adverse drug reactions.
    Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
    Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P-450 gene and drug interaction analysis in patients referred for pharmacogenetic testing.
    Hocum BT; White JR; Heck JW; Thirumaran RK; Moyer N; Newman R; Ashcraft K
    Am J Health Syst Pharm; 2016 Jan; 73(2):61-7. PubMed ID: 26721535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
    Sim SC; Kacevska M; Ingelman-Sundberg M
    Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of pharmacogenetics of adverse drug reactions in elderly people.
    Cardelli M; Marchegiani F; Corsonello A; Lattanzio F; Provinciali M
    Drug Saf; 2012 Jan; 35 Suppl 1():3-20. PubMed ID: 23446782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding and preventing drug-drug and drug-gene interactions.
    Tannenbaum C; Sheehan NL
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):533-44. PubMed ID: 24745854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dermatology in pharmacogenomics: drug-induced skin injury.
    Borroni RG
    Pharmacogenomics; 2015; 16(4):401-12. PubMed ID: 25823788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in special populations - the elderly.
    Davies EA; O'Mahony MS
    Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.
    Pilgrim JL; Gerostamoulos D; Drummer OH
    Forensic Sci Med Pathol; 2011 Jun; 7(2):162-84. PubMed ID: 21052868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.